Beijing Chunlizhengda Medical Instruments Co., Ltd. (Chunli Medical) reported no changes to either its authorised or issued share capital for March 2026, according to the monthly return submitted on 02 April 2026.

Authorised share capital • Ordinary shares remain at 383.57 million, divided into 95.14 million H shares and 288.43 million A shares, each with a par value of RMB 1.

Issued share capital • H shares: 95.14 million in issue, unchanged month-on-month, with no treasury balance. • A shares: 288.43 million in issue, including 1.38 million held as treasury shares; the outstanding free-float A shares therefore stand at 287.05 million. • Combined issued shares (excluding treasury) total 382.19 million.

Treasury position • The 1.38 million A shares held in treasury represent approximately 0.48 % of the A-share class and 0.36 % of total issued shares. No share repurchases occurred during the month.

Public-float confirmation • Management affirmed that the H-share free float exceeds the 5 % minimum required of PRC issuers with other listed shares, meeting Main Board Rule 13.32D(1).

Capital-raising instruments • The issuer reported no outstanding share options, warrants, convertibles or other agreements that could dilute current shareholders.

Regulatory confirmations • The filing confirms that all listing-rule obligations and statutory requirements were met and that no new securities were issued during the period.

In sum, Chunli Medical’s equity structure and regulatory standing remain unchanged for March 2026, underscoring a period of capital stability.